Daré Bioscience, Inc. beat EPS estimates 100% of the time across 3 reported quarters (3 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-0.33 | $-0.20 | +39.4% | Beat |
| Q12026 FY2026 | $-0.33 | $-0.20 | +39.4% | Beat |
| Q42025 FY2025 | $-0.24 | $-0.02 | +91.7% | Beat |
Back to DARE overview · DARE holders · DARE KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.